Placidyl

Placidyl (also known as Ethchlorvynol) is a sedative and hypnotic medication developed in the mid-20th century. It was primarily used in the treatment of insomnia and has been largely discontinued due to its potential for misuse and addiction.

History

Placidyl was developed by the pharmaceutical company Abbott Laboratories in the 1950s. It was marketed as a safer alternative to barbiturates, which were commonly used at the time for the treatment of insomnia. However, Placidyl was found to have a high potential for misuse and addiction, leading to its discontinuation in many countries.

Pharmacology

Ethchlorvynol, the active ingredient in Placidyl, is a GABA agonist. It works by increasing the activity of GABA, a neurotransmitter that inhibits the activity of the nervous system. This results in a calming effect, making it effective in the treatment of insomnia.

Side Effects

Common side effects of Placidyl include drowsiness, dizziness, and confusion. More serious side effects can include respiratory depression, dependence, and withdrawal symptoms upon discontinuation.

Legal Status

Placidyl is a Schedule IV controlled substance in the United States, indicating that it has a low potential for abuse and low risk of dependence. However, it is no longer commercially available in many countries due to its potential for misuse and addiction.

See Also

• Barbiturates
• GABA
• Insomnia
• Abbott Laboratories

Placidyl Resources
Latest articles Most recent articles Ongoing trials	Wikipedia